Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
2.475 USD | -6.60% | -7.38% | +47.65% |
Apr. 23 | Capital One Starts Heron Therapeutics With Overweight Rating, $6 Price Target | MT |
Mar. 21 | Heron Therapeutics, Inc. Announces Executive Changes, Effective March 29, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+47.65% | 398M | |
+0.99% | 43.84B | |
+6.27% | 41.68B | |
+45.04% | 41.25B | |
-10.92% | 27.04B | |
+8.24% | 25.53B | |
-25.08% | 18.18B | |
-3.84% | 12.29B | |
+25.30% | 12.29B | |
+6.99% | 11.15B |
- Stock Market
- Equities
- HRTX Stock
- News Heron Therapeutics, Inc.
- Heron Therapeutics to Cut Workforce by 34% Under Restructuring Plan